Tenon Medical, Inc.
Datakwaliteit: 100%
€ 0,73
▼
€ 0,01
(-1,35%)
Marktkapitalisatie: 8,26 M
Prijs
€ 0,73
Marktkapitalisatie
8,26 M
Dagbereik
€ 0,72 — € 0,74
52-Weeksbereik
€ 0,64 — € 2,48
Volume
57.520
Openen € 0,73
50D / 200D Gem.
€ 0,80
8,36% below
50D / 200D Gem.
€ 1,06
31,04% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -11,02 M
Capital efficient — spends only 6,92% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)20,35%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-218,16%
Onder sectorgemiddelde (-53,41%)
ROIC-127,31%
Net Margin-318,36%
Op. Margin-324,34%
Veiligheid
Debt / Equity
N/A
Current Ratio2,15
Interest Coverage-376,24
Waardering
PE (TTM)
-0,66
Boven sectorgemiddelde (-1,48)
P/B Ratio1,72
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -0,7 | -1,5 |
| P/B | 1,7 | 1,6 |
| ROE % | -218,2 | -53,4 |
| Net Margin % | -318,4 | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20,35% | Revenue Growth (3Y) | 16,06% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3,94 M | Net Income (TTM) | -12,56 M |
| ROE | -218,16% | ROA | -116,91% |
| Gross Margin | 59,79% | Operating Margin | -324,34% |
| Net Margin | -318,36% | Free Cash Flow (TTM) | -11,02 M |
| ROIC | -127,31% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2,15 |
| Interest Coverage | -376,24 | Asset Turnover | 0,37 |
| Working Capital | 3,50 M | Tangible Book Value | 1,89 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,66 | Forward P/E | N/A |
| P/B Ratio | 1,72 | P/S Ratio | 2,09 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -133,37% | ||
| Market Cap | 8,26 M | Enterprise Value | 4,82 M |
| Per Share | |||
| EPS (Diluted TTM) | -1,70 | Revenue / Share | 0,35 |
| FCF / Share | -0,98 | OCF / Share | -0,95 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 6,92% | FCF Conversion | 87,75% |
| SBC-Adj. FCF | -13,28 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 3,94 M | 3,28 M | 2,93 M | 691.000,0 |
| Net Income | -12,56 M | -13,67 M | -15,58 M | -18,92 M |
| EPS (Diluted) | -1,70 | -11,26 | -8,59 | -2,36 |
| Gross Profit | 2,36 M | 1,71 M | 1,24 M | -641.000,0 |
| Operating Income | -12,79 M | -13,77 M | -15,73 M | -18,73 M |
| EBITDA | — | — | — | — |
| R&D Expenses | 2,15 M | 2,60 M | 3,16 M | 2,83 M |
| SG&A Expenses | — | — | — | — |
| D&A | 262.000,0 | 408.000,0 | 199.000,0 | — |
| Interest Expense | 34.000,0 | 34.000,0 | 21.000,0 | 354.000,0 |
| Income Tax | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 10,76 M | 9,84 M | 6,35 M | 11,09 M |
| Total Liabilities | 5,72 M | 3,87 M | 5,57 M | 4,84 M |
| Shareholders' Equity | 5,04 M | 5,97 M | 778.000,0 | 6,25 M |
| Total Debt | — | — | — | — |
| Cash & Equivalents | 3,76 M | 6,54 M | 2,43 M | 2,13 M |
| Current Assets | 6,77 M | 8,21 M | 3,89 M | 9,35 M |
| Current Liabilities | 3,21 M | 1,87 M | 3,14 M | 2,53 M |
{"event":"ticker_viewed","properties":{"ticker":"TNON","listing_kind":"stock","pathname":"/stocks/tnon","exchange":"Nasdaq","country":"US"}}